<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/8136</identifier>
				<datestamp>2021-05-28T07:32:43Z</datestamp>
				<setSpec>aabp:RS</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Pharmacokinetics of cannabidiolic acid in cattle following oral dosing of industrial hemp (Cannabis sativa)</dc:title>
	<dc:creator xml:lang="en">Kleinhenz, M. D. </dc:creator>
	<dc:creator xml:lang="en">Magnin, G.</dc:creator>
	<dc:creator xml:lang="en">Lin, J. </dc:creator>
	<dc:creator xml:lang="en">Griffin, J. </dc:creator>
	<dc:creator xml:lang="en">Kleinhenz, K. E. </dc:creator>
	<dc:creator xml:lang="en">Curtis, A.</dc:creator>
	<dc:creator xml:lang="en">Martin, M.</dc:creator>
	<dc:creator xml:lang="en">Coetzee, J. F.</dc:creator>
	<dc:subject xml:lang="en">Industrial hemp</dc:subject>
	<dc:subject xml:lang="en">nutritional value</dc:subject>
	<dc:subject xml:lang="en">therapeutic value</dc:subject>
	<dc:subject xml:lang="en">cannabinoid compounds</dc:subject>
	<dc:subject xml:lang="en">pharmacokinetics</dc:subject>
	<dc:description xml:lang="en">Industrial hemp (IH) (Cannabis sativa containing &amp;lt;0.3% tetrahydrocannabinol [THC]) has gained recent traction as a novel agricultural commodity. Hemp plants and byproducts are considered to have nutritional and potentially therapeutic value. The presence of bioactive cannabinoid compounds including cannabidiol (CBD), cannabidiolic acid (CBDA), and 9-tetrahydrocannabolic acid (THCA-A) in hemp may result in drug residues in edible tissues that pose a food safety risk to the consumer. The absence of published data describing the pharmacokinetics of cannabinoids in livestock is a significant impediment to research.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2020-09-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/aabp/article/view/8136</dc:identifier>
	<dc:identifier>10.21423/aabppro20208136</dc:identifier>
	<dc:source xml:lang="en">American Association of Bovine Practitioners  Conference Proceedings; 2020; 391</dc:source>
	<dc:source>1079-9737</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/aabp/article/view/8136/8080</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2020 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
